Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Athersys (DE:4LSA)
FRANKFURT:4LSA
Athersys (4LSA) Stock Price & Analysis
0 Followers
4LSA Stock Chart & Stats
Day’s Range€0.04 - €0.2
52-Week Range― - ―
Previous Close€0.05
Volume0.00
Average Volume (3M)N/A
Market Cap
$908.18K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Mar 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Athersys News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
2.49% Other Institutional Investors
97.51% Public Companies and
Individual Investors
4LSA FAQ
What was Athersys’s price range in the past 12 months?
Currently, no data Available
What is Athersys’s market cap?
Currently, no data Available
When is Athersys’s upcoming earnings report date?
Athersys’s upcoming earnings report date is Mar 12, 2024 which is 54 days ago.
How were Athersys’s earnings last quarter?
Athersys released its earnings results on Nov 16, 2023. The company reported -€0.138 earnings per share for the quarter, beating the consensus estimate of -€0.193 by €0.055.
Is Athersys overvalued?
According to Wall Street analysts Athersys’s price is currently Overvalued.
Does Athersys pay dividends?
Athersys does not currently pay dividends.
What is Athersys’s EPS estimate?
Athersys’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Athersys have?
Currently, no data Available
What happened to Athersys’s price movement after its last earnings report?
Athersys reported an EPS of -€0.138 in its last earnings report, beating expectations of -€0.193. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Athersys?
Currently, no hedge funds are holding shares in DE:4LSA
---
Athersys Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-97.36%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-79.10%
Trailing 12-Months
Company Description
Athersys
Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.
---
4LSA Earnings Call
Q3 2022
0:00 / 0:00
---
4LSA Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Athersys
―
BioMarin Pharmaceutical
―
Sangamo Biosciences
―
Sarepta Therapeutics
―
Voyager Therapeutics
―
Best Analysts Covering 4LSA
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-98.60%
initiated a buy rating a year ago
Copying James Molloy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -98.60% per trade.
---